Tools

LEADER 03411nam a2200565 a 4500

001 EBC807159;

003 MiAaPQ;

005 20190726095316.0;

006 m o d | ;

007 cr cn|||||||||;

008 110719s2011 enka sb 001 0 eng d;

010 z| 2011030483;

020 z| 9780521766272 (hardback);

020 z| 9781139157315 (e-book);

035 a| (Sirsi) o773039601;

035 a| (MiAaPQ)EBC807159;

035 a| (Au-PeEL)EBL807159;

035 a| (CaPaEBR)ebr10514271;

035 a| (CaONFJC)MIL334227;

035 a| (OCoLC)769342277;

040 a| MiAaPQc| MiAaPQd| MiAaPQd| UtOrBLW;

050 4 a| RC377b| .M85 2011eb;

082 04 a| 616.8/342| 23;

245 00 a| Multiple sclerosis therapeutics /c| edited by Jeffrey A. Cohen, Richard A. Rudick.;

250 a| 4th ed.;

260 a| Cambridge :b| Cambridge University Press,c| 2011.;

300 a| xvii, 752 pages :b| illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

504 a| Includes bibliographical references and index.;

505 8 a| Machine generated contents note: Part I. Introduction; Part II. Clinical Trial Methodology; Part III. Clinical Trials of Multiple Sclerosis Therapies; Part IV. Therapy in Clinical Practice.;

520 a| "This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management. The status of the rapidly evolving field of disease-modifying drugs is presented, with emphasis on the most promising therapies currently being tested. Experts discuss disease and symptom management for MS subtypes, including neuromyelitis optica and pediatric MS. In addition, key scientific advances in MS pathology, genetics, immunology and epidemiology are presented. The fourth edition has been extensively revised, featuring more than 50% new material. All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years. This book is an essential reference for practitioners caring for MS patients, investigators planning or conducting clinical trials, and clinical trial sponsors"--Provided by publisher.;

533 a| Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.;

650 0 a| Multiple sclerosisx| Treatment.;

655 4 a| Electronic books.;

700 1 a| Cohen, Jeffrey A.q| (Jeffrey Alan),d| 1954-;

700 1 a| Rudick, Richard A.;

710 2 a| ProQuest (Firm);

856 40 u| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=807159z| Click to View;

949 a| Click on web addressw| asish| joyner96o| jjlm;

949 a| Click on web addressw| asish| hsl102o| jjlm;

096 a| WL 360 M961 2011;

590 a| Laupus-WCP;

596 a| 1 4;

998 a| 2678013;

096 a| WL 360 M961 2011;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 2678013-1001l| HSLELECm| HSLp| $210.00r| Ys| Yt| HGENEBKu| 1/30/2012x| EBOOKz| HERESOURCE0| HSLo| .STAFF. hgmb;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 2678013-2001l| JNETm| JOYNERr| Ys| Yt| JNE3BKu| 1/30/2012x| EBOOKz| JERESOURCEo| .STAFF. hgmb;

Multiple sclerosis therapeutics / edited by Jeffrey A. Cohen, Richard A. Rudick.

Other author	Cohen, Jeffrey A. (Jeffrey Alan), 1954-
Other author	Rudick, Richard A.
Other author	ProQuest (Firm)
Format	Electronic
Edition	4th ed.
Publication Info	Cambridge : Cambridge University Press, 2011.
Description	xvii, 752 pages : illustrations
Supplemental Content	Click to View
Subjects	Multiple sclerosis--Treatment.

Contents	Machine generated contents note: Part I. Introduction; Part II. Clinical Trial Methodology; Part III. Clinical Trials of Multiple Sclerosis Therapies; Part IV. Therapy in Clinical Practice.
Abstract	"This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management. The status of the rapidly evolving field of disease-modifying drugs is presented, with emphasis on the most promising therapies currently being tested. Experts discuss disease and symptom management for MS subtypes, including neuromyelitis optica and pediatric MS. In addition, key scientific advances in MS pathology, genetics, immunology and epidemiology are presented. The fourth edition has been extensively revised, featuring more than 50% new material. All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years. This book is an essential reference for practitioners caring for MS patients, investigators planning or conducting clinical trials, and clinical trial sponsors"--Provided by publisher.
Local note	Laupus-WCP
Bibliography note	Includes bibliographical references and index.
Reproduction note	Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Genre/form	Electronic books.
LCCN	2011030483

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Multiple sclerosis therapeutics / edited by Jeffrey A. Cohen, Richard A. Rudick.

Click here for more information about this title

Availability